HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 52 | 54 | 96.3% | |
| HF004 | 2020 | 54 | 58 | 93.1% | |
| HF006 | 2021 | 82 | 90 | 91.1% | |
| HF006 | 2022 | 113 | 114 | 99.1% | |
| HF006 | 2023 | 121 | 126 | 96.0% |
